X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2535) 2535
Book Review (363) 363
Publication (246) 246
Book Chapter (32) 32
Conference Proceeding (13) 13
Web Resource (2) 2
Book / eBook (1) 1
Data Set (1) 1
Dissertation (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2139) 2139
humans (1982) 1982
oncology (1057) 1057
female (999) 999
frequent (997) 997
male (842) 842
mutation (814) 814
middle aged (689) 689
cancer (655) 655
adult (588) 588
aged (569) 569
mutations (463) 463
frequent loss (438) 438
genetics & heredity (429) 429
expression (418) 418
genetic aspects (417) 417
animals (347) 347
tumors (347) 347
pathology (338) 338
gene (299) 299
tumor-suppressor gene (280) 280
loss of heterozygosity (279) 279
biochemistry & molecular biology (278) 278
polymerase chain reaction (278) 278
prognosis (278) 278
research (275) 275
genes (267) 267
base sequence (251) 251
cell biology (251) 251
heterozygosity (250) 250
aged, 80 and over (245) 245
dna methylation (242) 242
immunohistochemistry (241) 241
molecular sequence data (241) 241
analysis (236) 236
carcinoma (233) 233
dna mutational analysis (222) 222
gene expression (208) 208
gene expression regulation, neoplastic (204) 204
mice (198) 198
genes, tumor suppressor (193) 193
identification (191) 191
methylation (187) 187
adolescent (168) 168
p53 (168) 168
hematology (165) 165
cell line, tumor (164) 164
article (162) 162
proteins (156) 156
protein (153) 153
clinical neurology (150) 150
genetics (149) 149
somatic mutations (146) 146
tumor cells, cultured (146) 146
abridged index medicus (144) 144
gene deletion (143) 143
breast-cancer (142) 142
adenocarcinoma - genetics (140) 140
alleles (140) 140
mutation - genetics (140) 140
phenotype (140) 140
gene mutations (139) 139
microsatellite instability (138) 138
lung-cancer (137) 137
dna (136) 136
genomics (136) 136
health aspects (133) 133
child (132) 132
carcinomas (128) 128
genetic research (128) 128
polymorphism, single-stranded conformational (128) 128
lung neoplasms - genetics (127) 127
adenocarcinoma (126) 126
frequent cause (123) 123
dna, neoplasm - genetics (122) 122
reverse transcriptase polymerase chain reaction (121) 121
genomes (119) 119
carcinoma, squamous cell - genetics (117) 117
colorectal-cancer (116) 116
beta-catenin (115) 115
neoplasm staging (115) 115
neoplasms - genetics (115) 115
medicine, research & experimental (114) 114
microsatellite repeats (114) 114
stomach neoplasms - genetics (113) 113
sequence analysis, dna (112) 112
young adult (111) 111
tumor suppressor proteins - genetics (110) 110
risk factors (106) 106
signal transduction (106) 106
tumor suppressor genes (105) 105
chromosome mapping (104) 104
frequent epigenetic inactivation (104) 104
nuclear proteins - genetics (104) 104
genes, p53 (102) 102
liver neoplasms - genetics (102) 102
deletion (101) 101
development and progression (100) 100
frequent mutations (100) 100
neurosciences (100) 100
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2540) 2540
French (15) 15
German (11) 11
Chinese (2) 2
Japanese (2) 2
Russian (2) 2
Hungarian (1) 1
Polish (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 08/2012, Volume 367, Issue 9, pp. 826 - 833
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2011, Volume 365, Issue 15, pp. 1384 - 1395
Journal Article
Nature Genetics, ISSN 1061-4036, 2014, Volume 46, Issue 2, pp. 171 - 175
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2014, Volume 9, Issue 12, pp. e115383 - e115383
Background: Cholangiocarcinoma (CCA) is clinically heterogeneous; intra and extrahepatic CCA have diverse clinical presentations. Next generation sequencing... 
MORTALITY | INTRAHEPATIC CHOLANGIOCARCINOMA | MULTIDISCIPLINARY SCIENCES | ERBB2 | GALLBLADDER CANCER | FREQUENT MUTATION | IDENTIFICATION | EXPRESSION | TRENDS | BAP1 | EPIDEMIOLOGY | Multivariate Analysis | Demography | Prognosis | Humans | Middle Aged | Male | Molecular Targeted Therapy | Tumor Suppressor Protein p53 - genetics | Young Adult | DNA Mutational Analysis | Receptors, Fibroblast Growth Factor - genetics | Aged, 80 and over | Adult | Female | Genes, Neoplasm - genetics | Bile Ducts, Intrahepatic - pathology | Cholangiocarcinoma - therapy | Treatment Outcome | Signal Transduction - genetics | Mutation - genetics | Genome, Human - genetics | Disease-Free Survival | Regression Analysis | Cholangiocarcinoma - pathology | Oncogene Proteins, Fusion - genetics | Cholangiocarcinoma - genetics | Aged | Genetic aspects | Tumor proteins | Health aspects | Cancer | TOR protein | Chromatin | Dehydrogenases | Profiling | Identification methods | Exons | p53 Protein | Genes | Lung cancer | Clinical trials | Medical records | Raf protein | Cancer therapies | DNA repair | Smad4 protein | Subgroups | Cdc4 protein | K-Ras protein | Metastases | Gene sequencing | Liver cancer | Gallbladder | Cholangiocarcinoma | Deoxyribonucleic acid--DNA | Medical research | Epidermal growth factor receptors | Review boards | Introns | MEK inhibitors | MAP kinase | Patients | ErbB-2 protein | Mcl-1 protein | Gene amplification | Chemotherapy | Medical prognosis | Mutation | Aberration | Fibroblast growth factor receptors | Index Medicus | Deoxyribonucleic acid | DNA
Journal Article
Leukemia, ISSN 0887-6924, 10/2017, Volume 31, Issue 10, pp. 2020 - 2028
Neomorphic mutations in isocitrate dehydrogenase 1 (IDH1) are frequently found in several human cancer types including acute myeloid leukemia (AML) and lead to... 
FREQUENT | IMPACT | ONCOLOGY | LEUKEMOGENESIS | GROWTH | 2-HYDROXYGLUTARATE LEVELS | MUTATIONS | DIFFERENTIATION | HEMATOLOGY | SUFFICIENT | Neoplastic Stem Cells - drug effects | Humans | Neoplasm Proteins - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Mutation, Missense | Isocitrate Dehydrogenase - antagonists & inhibitors | Molecular Targeted Therapy | Leukemia, Myeloid, Acute - enzymology | Histone Code - drug effects | Protein Processing, Post-Translational - drug effects | Leukemia, Myeloid, Acute - drug therapy | Myeloid Cells - drug effects | Antineoplastic Agents - pharmacology | Neoplasm Proteins - genetics | Myelopoiesis - drug effects | Benzimidazoles - therapeutic use | Tumor Stem Cell Assay | Aniline Compounds - pharmacology | Enzyme Inhibitors - pharmacology | Isocitrate Dehydrogenase - genetics | Enzyme Inhibitors - therapeutic use | Xenograft Model Antitumor Assays | Point Mutation | Animals | Methylation - drug effects | Cell Line, Tumor | Benzimidazoles - pharmacology | Glutarates - metabolism | Mice | Aniline Compounds - therapeutic use | Mutation | DNA Methylation - drug effects | Neoplastic Stem Cells - enzymology | Leukemia, Myeloid, Acute - genetics | Gene mutations | Health aspects | Isocitrate dehydrogenase | Animal models | Cell survival | Myeloid leukemia | Leukemia | Oral administration | Stem cell transplantation | Inhibitors | Allografts | Rodents | Stem cells | Xenografts | DNA methylation | Methylation | Differentiation | Acute myeloid leukemia | Deoxyribonucleic acid--DNA | Cancer | Index Medicus | Original
Journal Article
Nature Genetics, ISSN 1061-4036, 12/2013, Volume 45, Issue 12, pp. 1483 - 1486
Journal Article
by Peifer, Martin and Fernández-Cuesta, Lynnette and Sos, Martin L and George, Julie and Seidel, Danila and Kasper, Lawryn H and Plenker, Dennis and Leenders, Frauke and Sun, Ruping and Zander, Thomas and Menon, Roopika and Koker, Mirjam and Dahmen, Ilona and Müller, Christian and Di Cerbo, Vincenzo and Schildhaus, Hans-Ulrich and Altmüller, Janine and Baessmann, Ingelore and Becker, Christian and De Wilde, Bram and Vandesompele, Jo and Böhm, Diana and Ansén, Sascha and Gabler, Franziska and Wilkening, Ines and Heynck, Stefanie and Heuckmann, Johannes M and Lu, Xin and Carter, Scott L and Cibulskis, Kristian and Banerji, Shantanu and Getz, Gad and Park, Kwon-Sik and Rauh, Daniel and Grütter, Christian and Fischer, Matthias and Pasqualucci, Laura and Wright, Gavin and Wainer, Zoe and Russell, Prudence and Petersen, Iver and Chen, Yuan and Stoelben, Erich and Ludwig, Corinna and Schnabel, Philipp and Hoffmann, Hans and Muley, Thomas and Brockmann, Michael and Engel-Riedel, Walburga and Muscarella, Lucia A and Fazio, Vito M and Groen, Harry and Timens, Wim and Sietsma, Hannie and Thunnissen, Erik and Smit, Egber and Heideman, Daniëlle A. M and Snijders, Peter J. F and Cappuzzo, Federico and Ligorio, Claudia and Damiani, Stefania and Field, John and Solberg, Steinar and Brustugun, Odd Terje and Lund-Iversen, Marius and Sänger, Jörg and Clement, Joachim H and Soltermann, Alex and Moch, Holger and Weder, Walter and Solomon, Benjamin and Soria, Jean-Charles and Validire, Pierre and Besse, Benjamin and Brambilla, Elisabeth and Brambilla, Christian and Lantuejoul, Sylvie and Lorimier, Philippe and Schneider, Peter M and Hallek, Michael and Pao, William and Meyerson, Matthew and Sage, Julien and Shendure, Jay and Schneider, Robert and Büttner, Reinhard and Wolf, Jürgen and Nürnberg, Peter and Perner, Sven and Heukamp, Lukas C and Brindle, Paul K and Haas, Stefan and Thomas, Roman K
Nature Genetics, ISSN 1061-4036, 10/2012, Volume 44, Issue 10, pp. 1104 - 1110
Journal Article
Cancer, ISSN 0008-543X, 07/2001, Volume 92, Issue 1, pp. 136 - 145
Journal Article
Journal Article